Test of Drug for Diabetes in Jeopardy

The latest findings on Avandia, a top-selling diabetes drug, raise concerns both about its safety and about the way the manufacturer and the Food and Drug Administration have responded to signs of danger. It would be rash to make definitive judgments u

Federal regulators did not act on a recommendation from their safety reviewers several months ago that GlaxoSmithKline's diabetes drug Avandia should carry the strongest possible caution about heart attacks, Senator Charles Grassley said Thursday in a<

Heart Attack Risk Seen in Drug for Diabetes

Years Ago, Agency Was Warned of a Drug’s Risks

Viagra may help lift the spirits of flagging international travellers and shift workers as well as amorous males, claims a study published today.

What if medical care came with a 90-day warranty?

Doctors Reap Millions for Anemia Drugs

A review of the latest research in sexual adaptation shows that evidence is building for what researchers call “sperm competition.”

Johnson & Johnson Won’t Seek Approval for a Heart Stent

Study Shows Flu Season Increases Heart Ailments

The kids. The job. The house. The cell phone, blackberry and email.  With all the responsibilities many women juggle, there is often no time for romance, and in many cases, even less desire.  Well over a third (40 – 45%) of adult women

Pedaling a bicycle through the morning cold and fog is easy for the first mile. But there are 102 more miles to go on the Solvang Century.

Gene Identified as Risk Factor for Heart Ills

SOME gymgoers are tortoises. They prefer to take their sweet time, leisurely pedaling or ambling along on a treadmill. Others are hares, impatiently racing through miles at high intensity.

Death rates and heart failure in hospitalized heart attack patients have fallen sharply in the last six years, most likely because of better treatment, the largest international study of its kind suggests. The promising trend parallels the growing use<

In Moscow in 1996, a Doctor’s Visit Changed History

WHEN George Skouras, an investment manager in New York, turned 52, he decided to go for a complete physical exam. He felt perfectly healthy, but wanted to know if there was anything to worry about.

The Food and Drug Administration rejected Merck & Company's request to market a successor to its withdrawn arthritis drug Vioxx in the United States, the drug maker said. The decision was widely expected, after a panel of F.D.A. advisers two weeks<

There are few studies that address the subject of sexual function after reconstructive surgery for anterior urethral stricture disease.